NCT03415724

Brief Summary

Aim of the study is to determine and compare the anaesthetic efficacy of dexmedetomidine and epinephrine in combination with 2% lidocaine for inferior nerve block in patients with irreversible pulpitis. Study will be conducted in Post Graduate Institute of Dental Sciences, Rohtak in department of Conservative Dentistry \& Endodontics. Vital mature permanent mandibular molars with radiographically exposed dentinal caries and with signs of irreversible pulpitis will be included in the study. The patients will be randomly allocated into two control and two experimental groups and nerve block will be given according to standard protocol.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2018

Completed
2 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2018

Completed
Last Updated

February 1, 2018

Status Verified

January 1, 2018

Enrollment Period

3 months

First QC Date

December 29, 2017

Last Update Submit

January 31, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain intensity

    After giving inferior alveolar nerve block as per the standard protocol, conventional access opening will be initiated after isolation with a rubber dam. Patients will be instructed to raise their hand if any pain felt during the procedure and rate the pain on heft parker VAS scale.

    The root canal treatment will be completed in two sittings and the second sitting will be provided after 3-4 days.The time frame of the study is estimated to be about 6 months

Study Arms (4)

1.8 ml Lignocaine plus adrenaline

ACTIVE COMPARATOR

The study subjects will receive conventional inferior alveolar nerve block with 1.8 ml of 2% inj lignocaine with adrenaline 1:80000.

Procedure: Inferior alveolar nerve block

3.6 ml Lignocaine plus adrenaline

ACTIVE COMPARATOR

The study subjects will receive conventional inferior alveolar nerve block with 3.6 ml of 2% inj lignocaine with adrenaline 1:80000.

Procedure: Inferior alveolar nerve block

1.8 ml Lignocaine plus dexmedetomidine

ACTIVE COMPARATOR

conventional inferior alveolar nerve block with1.8 ml of injection lignocaine plus injection dexmedetomidiene 1micromol/ ml.

Procedure: Inferior alveolar nerve block

3.6 ml Lignocaine plus dexmedetomidine

ACTIVE COMPARATOR

conventional inferior alveolar nerve block with3.6 ml of injection lignocaine plus injection dexmedetomidiene 1micromol/ ml.

Procedure: Inferior alveolar nerve block

Interventions

Inferior alveolar nerve block will be given to patients having irreversible pulpitis in mandibular molars

1.8 ml Lignocaine plus adrenaline1.8 ml Lignocaine plus dexmedetomidine3.6 ml Lignocaine plus adrenaline3.6 ml Lignocaine plus dexmedetomidine

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years of age.
  • Patient willing to participate in the study.
  • Mature permanent mandibular first and second molars exhibiting signs of symptomatic irreversible pulpitis as assessed by history, cold and electric pulp tests.
  • Absence of periapical lesions on radiographic examination.

You may not qualify if:

  • Patient not ready to participate in the study voluntarily
  • Clinical history or electrocardiographic evidence of heart block, Ischaemic heart disease
  • Asthma, Sleep apnoea syndrome.
  • Impaired liver, renal or mental function.
  • Alcohol consumption in excess of 28 units per week.
  • Chronic sedative and analgesic user and those having known allergy to study drugs
  • Patients with severe periodontal disease.
  • Patients unable to return for recall appointments
  • Signs or symptoms of external /internal resorption, furcation or periapical radiolucency, swelling, or sinus tract.
  • Negative response to cold and electric pulp tests.
  • Antibiotic or analgesic intake within past 24 hours before treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Post Graduate Institute of Dental Sciences

Rohtak, Haryana, 124001, India

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2017

First Posted

January 30, 2018

Study Start

February 1, 2018

Primary Completion

April 30, 2018

Study Completion

April 30, 2018

Last Updated

February 1, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations